National workshop on Polyacrylamide Gel Electrophoresis & Immunodiagnostic Techniques at ADINA Institute of Pharmaceutical Sciences
National Workshop on
" Polyacrylamide Gel Electrophoresis & Immunodiagnostic Techniques"
Foreign Direct Investment (FDI) in Brownfield pharma sector has been permitted upto 74% under automatic route; and FDI beyond 74% and upto 100% is allowed under Government approval route.
The Competition Commission of India (Commission) has found the Karnataka Chemists and Druggist Association (KCDA) and Lupin Ltd. (Lupin) to be in contravention of the provisions of the Competition Act, 2002 (the Act). In a case filed by M/s Maruti & Co., it was brought to the notice of the Commission that KCDA restraints pharmaceutical companies from appointing new stockists in the State of Karnataka unless a No Objection Certificate (NOC) is obtained from it.
Vanda Pharmaceuticals Inc. (Vanda), a specialty pharmaceutical company, announced that Hetlioz (tasimelteon) is now available for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) in Germany.
All animals begin life as a single cell from which arise the many different cell types, such as heart, lung, blood, etc., that are specific to that type of animal. However, once the process of cell differentiation has led to many different tissues, each organism has a new, opposite imperative – keeping new cells in each type of tissue the same as their brethren. Cancers arise in a tissue when a cell becomes different from its neighbors and thus represent a failure to maintain this critical uniformity.
Pfizer Inc. announced top-line results from Oral Clinical Trials for tofAcitinib in ulceratiVE colitis (OCTAVE) Sustain, the third phase 3 study of Xeljanz (tofacitinib citrate) being investigated in patients with moderately to severely active ulcerative colitis (UC). OCTAVE Sustain is a 52 week study that evaluated oral tofacitinib 5 mg and 10 mg twice daily (BID) as a maintenance treatment in adult patients with moderately to severely active UC who previously completed and achieved clinical response in either the OCTAVE Induction 1 or OCTAVE Induction 2 studies.